Benutzer: Gast  Login
Titel:

Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.

Dokumenttyp:
Clinical Trial, Phase II; Journal Article; Article
Autor(en):
von Delius, S; Lersch, C; Schulte-Frohlinde, E; Mayr, M; Schmid, RM; Eckel, F
Abstract:
BACKGROUND: Patients with advanced gallbladder and biliary tract carcinoma face a dismal prognosis, as no effective palliative chemotherapy exists. The antitumor effect of gemcitabine is schedule-dependent rather than dose-dependent. We evaluated the activity of a prolonged infusion of gemcitabine in advanced gallbladder and biliary tract carcinomas. METHODS: Nineteen consecutive eligible patients were enrolled. All patients were required to have histologically confirmed diagnosis and measurable...     »
Zeitschriftentitel:
BMC Cancer
Jahr:
2005
Band / Volume:
5
Heft / Issue:
1
Seitenangaben Beitrag:
61
Sprache:
eng
Volltext / DOI:
doi:10.1186/1471-2407-5-61
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/15949047
TUM Einrichtung:
II. Medizinische Klinik und Poliklinik (Gastroenterologie)
 BibTeX